Abstract
Classification and characterisation of cellular morphological states are vital for understanding cell differentiation, development, and diverse pathological conditions. This study presents a three-dimensional (3D) nuclear texture description method, 3D Sorted Random Projections (SRP), for cell nucleus classification and variation measurement in chromatin patterns. By incorporating inter-slice intensity correlations through hyperplane generation in cubical patches, the proposed method captures heterogeneous information across multiple dimensions. Evaluated on human fibroblast and prostate cancer cell lines, the 3D SRP descriptor achieved near-perfect classification accuracy, outperforming traditional handcrafted features and deep learning models. These results validate nuclear texture as a reliable biomarker for cellular identity and early disease diagnosis.
Introduction
The spatial organization of DNA within the nucleus—chromatin—serves as a sensitive indicator of a cell's health and phenotypic state. Transitions to cancerous states or different developmental stages often manifest as shifts in chromatin texture, such as the formation of dense heterochromatin (HC) or open euchromatin (EC). While confocal microscopy provides high-resolution 3D data, traditional analysis often relies on 2D projections or "pseudo-3D" methods that ignore vertical spatial correlations. This paper introduces a robust, interpretable 3D texture descriptor designed to quantify these subtle morphological shifts, even in low-resolution volumetric images.
Methodology: 3D Sorted Random Projections
The core innovation of this research is the extension of the Sorted Random Projections (SRP) texture feature into the third dimension. The workflow begins with a segmentation pipeline to isolate individual nuclei from noisy microscopic images using adaptive thresholding and watershed algorithms. This process ensures that even closely packed cells are accurately identified for subsequent analysis.
The 3D SRP descriptor then extracts "cubic patches" from the volumetric data. Unlike standard methods that analyze slices independently, this approach constructs multiple "hyperplanes" (slanted planes) within these cubes to capture texture information in all directions, effectively modeling inter-slice correlations.
To maintain computational efficiency, the high-dimensional texture data is compressed using Random Projections (RP), which preserves the distances between data points without requiring the massive training sets typical of deep learning. Furthermore, the authors developed specific metrics to quantify the ratio of heterochromatin to euchromatin, providing a direct biological interpretation of the observed texture changes.
Experimental Results and Discussion
The proposed method was evaluated using the SOCR 3D Cell Nuclear Morphology Dataset, focusing on two critical transitions:
- Human Fibroblasts: Proliferating (PROLIF) vs. serum-starved (SS) states.
- Human Prostate Cancer (PC3): Epithelial (EPI) vs. mesenchymal transition (EMT) states.
The 3D SRP method demonstrated exceptional performance, achieving an AUC of 1.0 and an F1 score of 0.99 for the fibroblast dataset, and an AUC of 1.0 with an F1 score of 0.98 for the prostate cancer dataset. Statistical analysis (t-tests, p < 0.01) confirmed that the true 3D approach significantly outperformed pseudo-3D methods, highlighting the necessity of capturing Z-axis texture.
Interestingly, the handcrafted 3D SRP feature outperformed deep learning models like VGG-16 pre-trained on ImageNet. This suggests that in specialized biomedical domains where data is scarce, domain-specific feature engineering can be more effective than general-purpose deep learning, providing both higher accuracy and better interpretability for clinical researchers.
Conclusion
This study validates that nuclear texture is a powerful phenotypic fingerprint. As cells transition between states, measurable changes in the intensity and aggregation of heterochromatin occur. The 3D SRP descriptor provides a robust tool for early diagnosis and prognosis by detecting these small-scale abnormalities. Future work aims to extend this descriptor into the temporal dimension (4D) to track chromatin evolution in real-time during disease progression or drug treatment.
Summary updated